PQ 272
272. Deputy Michael McGrath asked the Minister for Health the HSE's policy in relation to sodium valproate being taken by a woman through pregnancy; the research that has been carried out here on the issue; and if he will make a statement on the matter. [47667/17]
Introduced
14 November 2017
Last action
14 November 2017 · Medicinal Products
Status
written
Sponsors
McGrath, Michael.
Subjects
Discovery layer
Source updated
14 November 2017
Summary
272. Deputy Michael McGrath asked the Minister for Health the HSE's policy in relation to sodium valproate being taken by a woman through pregnancy; the research that has been carried out here on the issue; and if he will make a statement on the matter. [47667/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 November 2017
Medicinal Products
272. Deputy Michael McGrath asked the Minister for Health the HSE's policy in relation to sodium valproate being taken by a woman through pregnancy; the research that has been carried out here on the issue; and if he will make a statement on the matter. [47667/17]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 14 November 2017
Sponsors
- McGrath, Michael. · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-11-14/272/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-11-14/pq_272
- ireland · q-2017-11-14-pq_272 · source updated 14 November 2017